← Insider buys

TPTX

Turning Point Therapeutics, Inc.

No insider bought or sold Turning Point Therapeutics, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo

TPTX over the last year

Prices for TPTX aren't in yet.

TPTX after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

49 insider filings since 2019, newest first

TPTXSell

Paolo Tombesi · EVP and CFO

$89K−4.0%Jul 29
TPTXSell

Athena Countouriotis · President and CEO

$108K−3.0%Feb 11
TPTXSell

Annette North · EVP, GC, Secty.

$800K−45.0%Aug 31
TPTXSell

Andrew John Partridge · EVP and Chief Commercial Officer

$140K−8.0%Jul 15
TPTXSell

Annette North · EVP, GC, Secty.

$1.2M−55.0%Jun 16
TPTXSell

Brian Lee Baker · SVP of Finance, Admin.

$2.9M−87.0%Mar 24
TPTXSell

Annette North · EVP, GC, Secty.

$2.2M−76.0%Mar 9
TPTXSell

Siegfried Reich · EVP and Chief Scientific Officer

$3.7M−90.0%Mar 5
TPTXSell

Athena Countouriotis · President and CEO

$8.2M−54.0%Feb 11
TPTXSell

Annette North · EVP, GC, Secty.

$3.1M−100.0%Feb 2
TPTXSell

Yi Larson · EVP and CFO

$3.8M−92.0%Feb 2
TPTXSell

Brian Lee Baker · SVP of Finance, Admin.

$3.8M−97.0%Jan 8
TPTXSell

Mohammad Hirmand · EVP and Chief Medical Officer

$1.2M−97.0%Jan 5
TPTXSell

Jingrong Jean Cui · Director

$625K−1.0%Jun 10
TPTXSell

Jingrong Jean Cui · Director

$3.6M−3.0%Jun 8
TPTXBuy

Simeon George · Director

$5.0M+4.0%May 26
TPTXBuy

Glaxosmithkline Plc · Director

$5.0M+4.0%May 26
TPTXBuy

Athena Countouriotis · President and CEO

$250K+18.0%May 26
TPTXSell

Jingrong Jean Cui · Director

$1.2M−1.0%May 21
TPTXSell

Jingrong Jean Cui · Director

$619K−1.0%May 12
TPTXSell

Jingrong Jean Cui · Director

$3.0M−3.0%May 7
TPTXSell

Jingrong Jean Cui · Director

$1.1M−1.0%Apr 24
TPTXSell

Jingrong Jean Cui · Director

$581K−1.0%Apr 13
TPTXSell

Jingrong Jean Cui · Director

$2.5M−3.0%Apr 8
TPTXSell

Jingrong Jean Cui · Director

$529K−1.0%Mar 27
TPTXSell

Jingrong Jean Cui · Director

$1.4M−1.0%Mar 25
TPTXSell

Jingrong Jean Cui · Director

$1.8M−2.0%Mar 12
TPTXSell

Jingrong Jean Cui · Director

$1.1M−1.0%Feb 26
TPTXSell

Jingrong Jean Cui · Director

$711K−1.0%Feb 14
TPTXSell

Jingrong Jean Cui · Director

$3.6M−3.0%Feb 12
TPTXSell

Jingrong Jean Cui · Chief Scientific Officer

$1.2M−1.0%Jan 29
TPTXSell

Jingrong Jean Cui · Chief Scientific Officer

$611K−1.0%Jan 17
TPTXSell

Jingrong Jean Cui · Chief Scientific Officer

$3.0M−2.0%Jan 14
TPTXSell

Jingrong Jean Cui · Chief Scientific Officer

$3.0M−2.0%Dec 20
TPTXSell

Jingrong Jean Cui · Chief Scientific Officer

$2.4M−2.0%Dec 17
TPTXSell

Jingrong Jean Cui · Chief Scientific Officer

$1.9M−3.0%Dec 12
TPTXSell

Jingrong Jean Cui · Chief Scientific Officer

$6.1M−5.0%Dec 9
TPTXBuy

Glaxosmithkline Plc · Director

$8.0M+9.0%Sep 12
TPTXBuy

Simeon George · Director

$8.0M+9.0%Sep 11
TPTXBuy

Yi Larson · EVP and CFO

$100KSep 11
TPTXBuy

Athena Countouriotis · President and CEO

$450K+83.0%Sep 11
TPTXBuy

Cormorant Asset Management, LP · 10% owner

$7.2M+15.0%Apr 25
TPTXBuy

Glaxosmithkline Plc · Director and 10% owner

$5.8M+19.0%Apr 24
TPTXBuy

Orbimed Advisors LLC · Director

$6.5M+22.0%Apr 24
TPTXBuy

Simeon George · Director

$5.8M+19.0%Apr 24
TPTXBuy

Hongbo Lu · Director

$1.1M+4.0%Apr 24
TPTXBuy

Carl L Gordon · Director

$6.5M+22.0%Apr 24
TPTXBuy

Brian Lee Baker · VP of Finance, Admin.

$50KApr 24
TPTXBuy

Athena Countouriotis · President and CEO

$216KApr 24

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.